Compare PNC & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNC | COR |
|---|---|---|
| Founded | 1852 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9B | 68.5B |
| IPO Year | 2010 | 2001 |
| Metric | PNC | COR |
|---|---|---|
| Price | $232.68 | $360.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 13 |
| Target Price | $232.00 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 2.5M | 1.3M |
| Earning Date | 04-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.95% | 0.67% |
| EPS Growth | ★ 7.43 | 5.71 |
| EPS | ★ 11.72 | 2.87 |
| Revenue | $21,555,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $16.51 | $8.94 |
| Revenue Next Year | $4.52 | $6.79 |
| P/E Ratio | ★ $19.62 | $125.27 |
| Revenue Growth | 0.30 | ★ 9.31 |
| 52 Week Low | $148.28 | $241.48 |
| 52 Week High | $243.94 | $377.54 |
| Indicator | PNC | COR |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 52.84 |
| Support Level | $227.88 | $347.03 |
| Resistance Level | $235.30 | $362.74 |
| Average True Range (ATR) | 5.28 | 11.61 |
| MACD | -1.22 | -0.09 |
| Stochastic Oscillator | 42.17 | 65.57 |
PNC Financial is one of the three super-regional banks in the US, with around $560 billion in total assets at the end of June 30, 2025. Headquartered in Pittsburgh, Pennsylvania, PNC Financial has a coast-to-coast branch network, with a strong presence in the US Midwest and Northeast. It is currently expanding in the Southern and Western regions of the US. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, asset management, and investment banking. PNC derived around 37% of revenue from fee income and 63% from net interest income in 2024.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.